gvtcx

supplier · GB-PPONPDQJ-6931-LMVQ

Kent Pharma Ltd

TN231FB combined from 2 published records

Kent Pharma Ltd has won 57 UK public sector awards from 10 buyers since 2020. The typical award is worth £32,809,976.

as a supplier

57 recorded awards from 10 buyers , between 13 Sept 2020 and 26 Aug 2026.

awards won
57
exclusive
2%
1 sole-winner awards
median award
£32.8m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Kent Pharma Ltd

How many public sector contracts has Kent Pharma Ltd won?

Kent Pharma Ltd has won 57 UK public sector contracts from 10 public bodies since 2020.

Which public bodies buy from Kent Pharma Ltd?

Kent Pharma Ltd has won the most contracts from NHS England, NHS England and Department of Health and Social Care (DHSC).

How large are Kent Pharma Ltd's contracts?

The median published value of a contract won by Kent Pharma Ltd is £32,809,976. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Kent Pharma Ltd contracts are expiring soon?

4 contracts involving Kent Pharma Ltd have end dates in the next 12 months, the earliest on 31 May 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £15,529,352 26 Aug 2026
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £21,026,178 26 Aug 2026
Generic Drugs – Injections/Infusions 2 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £5,857,450 3 Mar 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products shared NHS England £321,349,256 28 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £17,843,324 10 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products shared NHS England £11,656,086 15 Apr 2025
NHS National Framework for Transition products commencing 1 May 2024 shared NHS England £7,559,000 15 Apr 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 shared NHS England £688,010,000 26 Jan 2024
NHS London Branded Medicines - Tranche B - September 2023 shared NHS ENGLAND £231,083,000 13 Jul 2023
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS National Generic Pharmaceuticals Wave 14a shared NHS England £207,982,407 14 Dec 2022
NHS National Pharmaceuticals Transition 2022_1 shared NHS England £39,636,345 18 Jul 2022
NHS Framework Agreement for Branded Medicines - National shared NHS England £526,000,000 15 May 2022
Ciprofloxacin and doxycycline 2022-2023 Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency £1 26 Jan 2022
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,518 30 Nov 2021
NHS National Pharmaceuticals Transition 2021_3 shared NHS England £25,983,607 21 Oct 2021
NHS Framework Agreement for Branded Medicines - National shared NHS England £95,224,871 26 Sept 2021

every contract won by Kent Pharma Ltd →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Kent Pharma Ltd · · 48
Kent Pharma Ltd GB-PPON PDQJ-6931-LMVQ TN23 1FB 9

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 2 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.